{"id":"W2807732548","doi":"10.1111/dom.13413","title":"Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"National Institutes of Health; National Center for Advancing Translational Sciences; AstraZeneca","keywords":"Dapagliflozin; Medicine; Placebo; Renal function; Kidney disease; Type 2 diabetes; Internal medicine; Urology; Clinical endpoint; Adverse effect; Randomization; Diabetes mellitus; Gastroenterology; Randomized controlled trial; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002985001,0.0002562719,0.0005030337,0.0001224406,0.0001572216,0.00004348878,0.00007240355,0.00003892935,0.00003176336],"category_scores_gemma":[0.00005681509,0.0001584339,0.00002840509,0.0001815319,0.0003368637,0.000149905,0.0001831307,0.0001079342,0.000002435867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002939534,"about_ca_system_score_gemma":0.00006350319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002028591,"about_ca_topic_score_gemma":0.00001844926,"domain_scores_codex":[0.9986299,0.0001137925,0.0002497642,0.0003878878,0.0002511518,0.000367501],"domain_scores_gemma":[0.9991207,0.00005899533,0.0001013182,0.0003173914,0.0001028013,0.0002988137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008000066,0.001568978,0.9908077,0.000171102,0.0004895279,0.00000317423,0.0008948505,0.000003856491,0.0001162217,0.0001289306,0.00007098275,0.004944706],"study_design_scores_gemma":[0.01118509,0.001822133,0.9838769,0.0001552227,0.0008698378,3.103495e-8,0.00008428143,0.0002883575,0.0004976361,0.00005186409,0.0009986965,0.0001699297],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995755,0.002072877,0.000002324323,0.0001473662,0.00006806071,0.001805116,0.0000522351,0.00002160565,0.00007538001],"genre_scores_gemma":[0.9990483,0.0002602188,0.00007833086,0.0003030545,0.00006161848,0.00004181936,0.00005677603,0.00001959871,0.0001303197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01038508,"threshold_uncertainty_score":0.6460748,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005970261016607593,"score_gpt":0.2181164105582141,"score_spread":0.2121461495416065,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}